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AIMS AND OBJECTIVE 
 To find out the incidence of congenital Diaphragmatic Hernia in 
Government Rajaji Hospital, Madurai. 
 To evaluate the clinical presentation. 
 To find out the incidence of Congenital Diaphragmatic Hernia 
(CDH) diagnosed antenatally. 
 Total numbers treated and follow up for 1 year. 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
The migration of abdominal viscera through a defect in the 
diaphragm into the chest results in a diaphragmatic hernia. The congenital 
form exists as three distinct anatomical types: (i) Herniation through the 
posterolateral foramen of Bochdalek (ii) Herniation through the 
substernal foramen of Morgagni; and (iii) Herniation through the 
esophageal hiatus. 
The term 'congenital diaphragmatic hernia' (CDH) refers to the 
herniation of abdominal viscera through the posterolateral foramen of 
Bochdalek.  Congenital diaphragmatic hernia remains one of the most 
difficult challenges in the paediatric surgery.  The surgical aspects are 
relatively straight forward but the medical management of the associated 
pulmonary hypoplasia and pulmonary hypertension still eludes us.  With 
each passing decade, new approaches to the medical and surgical 
management of this entity have been advocated but have not stood the 
test of time.  The multitude of treatment options for CDH reflects our 
limited understanding of the pathophysiology and explains the relatively 
fixed mortality rate seen. 
 
REVIEW OF LITERATURE 
 
Historical Perspective: 
The first description of congenital diaphragmatic hernia was reported 
by Lazarus Riverius in the 17th Century in a 24 year old man.  Morgagni 
in 1796 discussed various types of diaphragmatic hernia and described 
the anterior defect which bears his name.  In 1848, Bochdalek described 
the posterolateral congenital diaphragmatic hernia and recognized the 
associated pulmonary hypoplasia. Broman suggested that nonclosure of 
the pleuroperitoneal canal could result in the dorsolateral diaphragmatic 
defect. 
 It was only in 1940 when Ladd and Gross reported 16 cases treated 
by surgery with 9 survivors. It was soon recognized that early surgery did 
not necessarily improve survival in congenital diaphragmatic hernia and 
that associated pulmonary hypoplasia and pulmonary hypertension 
determine outcome. The search for a specific pulmonary vasodilator 
continues. Preoperative stabilization and delayed surgery were proposed 
in the early 1980's.  In 1976, Bartlett and colleagues reported the first 
survivors of pulmonary hypertension treated with ECMO. The animal 
model of CDH in fetal lambs described by deLorimer et al (1967) was an 
important landmark in understanding the pathophysiology of the defect.  
Epidemiology 
In an analysis of 5 population based studies on the incidence of CDH, 
Katz et al reported an incidence of 0.3 per 1000 live births.1 Sweed and 
Puri reported 116 infants born with CDH in a discrete geographical 
population and reported an incidence of 0.315 per 1000 live births.2  The 
incidence of CDH depends on the denominator used. The 'hidden 
mortality' (i.e. those fetuses and neonates who die without recognition of 
the anomaly) in CDH defines the true incidence of the defect.  Puri and 
Gorman analyzed 47 cases of CDH in a hospital with an autopsy rate of 
100 for still births and neonatal deaths.3 They noted an incidence of 1 per 
2107 total births in this study.  The male to female ratio was 1:1.8 in this 
study and this female preponderance has been reported by other authors 
also. 
CDH is generally considered to be a sporadic anomaly, although 
some familial cases have been reported. Assuming multifactorial 
inheritance, the expected recurrence risk in a first degree relative is 
approximately 2%. Nongenetic etiological factors like thalidomide, 
quinine, nitrofen and a vitamin. A deficient diet has been implicated as 
causative factors for congenital diaphragmatic hernia. 
 
Embryology 
The nitrofen rat model of CDH allowed detailed study of abnormal 
diaphragmatic development.4 Kluth et al used scanning electron 
microscopy on normal rat embryos and rat embryos after nitrofen 
exposure to detail the embryogenesis of CDH.5 
The classical theory of diaphragmatic development attributes four 
sources for the diaphragm (i) the septum transversum forming the central 
tendon, (ii) mediastinum and dorsal mesogastrium of the esophagus 
forming the median portion and crura, (iii) pleuroperitoneal membranes 
forming a small dorsal portion and (iv) thoracic body wall musculature 
forming the major circumferential muscular part of the diaphragm. 
Kluth et al have described the normal embryology of the diaphragm 
in two phases: 
The diaphragm exists as a mass of mesenchyme between the 
epithelial linings of the pericardial and peritoneal cavities. The dorsal 
border is established by the pericardioperitoneal canals. The developing 
liver grows into the septum transversum causing its expansion in a 
ventrolateral direction.  The transverse septum is continuous with the 
dorsal structures via the pulmonary ridges laterally and the mediastinum 
medially.  The lateral pulmonary ridges are the forerunners of the 
pleuroperitoneal membranes. 
There is a controversy regarding the amount of contribution of the 
pleuroperitoneal membranes to form the diaphragm. Broman stated that 
most of the adult diaphragm was derived from it, whereas Wells believed 
that the pleuroperitoneal membranes have a minimal contribution in 
diaphragmatic development.  At the end of this first stage of 
development, the primitive diaphragm consists of the ventral transverse 
septum and the two dorsal pleuroperitoneal canals (PPC). 
Development of the pleural cavity and closure of the pleuroperitoneal 
canals (4th - 8th gestational week): 
The closure of the pleuroperitoneal canal (PPC) is believed to be crucial 
for normal diaphragmatic development. The theories described for 
closure of the PPC are - 
i. Development of the pleuroperitoneal membrane. 
ii. Dorsocranial development of the liver. 
iii. Bremer believed that the large suprarenal glands were important in 
the closure of the PPC. 
iv. Wells stated that the PPC was 'crowded out of existence' by the 
adjacent liver, gonads and suprarenal glands. 
v.   In 1984, Iritani described a new concept in the development of the 
diaphragm.6 He described the post hepatic mesenchymal plate 
(PHMP) as a mass of mesenchyme lying dorsal to the liver and 
ventral to the pleuroperitoneal canals.  
Kluth et al have shown that in the second phase of diaphragmatic 
development a system of folds appear in the pleural cavity that marks the 
borderline between the pleural and peritoneal cavity. With the growth of 
the liver and the PHMP the above mentioned folds form oval openings 
called the PPC. The liver serves as a matrix for the development and 
growth of the PHMP.  The closure of the PPC is completed by the eighth 
week and is primarily a result of the dorsolateral growth of the PHMP. 
 The muscularization of the diaphragm takes place by in situ 
myoblast differentiation or by migration of myoblasts from the cervical 
and occipital somites 
Lung Development 
Lung development is divided into 5 stages: 
 Embryonic stage (3-6 weeks): The lung originates as a ventral 
diverticulums form the caudal end of the laryngotracheal groove of 
the forgut in the 3rd week.  The diverticulum divides to form two 
lung buds (4th week) which further divide to form the lobar and 
subsequently the bronchopulmonary segments (6th week). 
 Pseudoglandular stage (6 - 16 weeks): The conducting airways 
(16 - 25 generations) are formed by repeated dichotomous 
branching.  The lung appears as multiple small epithelium lined 
tubules in a mass of mesenchyme. By the 16th week all bronchial 
airways are formed and no further increase in airway number 
occurs after this stage. Bronchial cartilage begins to be formed in 
this stage. 
 Canalicular phase (17-24 weeks):  In this stage the basic structure 
of the gas exchanging portion of the lung is formed and 
vascularized. The small blind ending channels become complex; 
the interstitial tissue decreases and capillary growth starts. Type-I 
pneumocytes appear at 20 weeks and at 22- 24 weeks, type-II 
pneumocytes with lamellar bodies can be identified. 
 Terminal saccular phase (24 weeks - term): There is a marked 
decrease in interstitial tissue and thinning of the air space walls. 
The distal airspaces divide into saccules, thus increasing the gas 
exchanging surface area. 
 Postnatal alveolar phase (Birth - 8 years): Mature alveoli 
appear at about the 5th week as around 20 million primitive 
terminal sacs. This increases to around 300 million alveoli by 8 
years of age with the maximum increase being in the first 4 years 
of life. 
Lung Development in CDH 
The size of the lungs in the 13 or 14 day old nitrofen-treated embryo 
is not different from that of a control group. Iritani has proposed primary 
lung hypoplasia as a cause of congenital diaphragmatic hernia.6 Kluth et 
al concluded from their studies that the hypoplastic lung results due to the 
ingrowth of the liver into the thoracic cavity. The ingrowing liver reduces 
the available space for the lung to grow properly. Since this defect occurs 
early in embryogenesis, spontaneous correction of these lung defects is 
unlikely even after fetal intervention.  The balloon studies in fetal sheep 
actually mimic congenital cystic adenomatoid malformation (CCAM) 
more than CDH.7-9.On the other hand, since congenital diaphragmatic 
hernia is an early embryological event, the lung defects are primarily 
structural and not as a result of direct compression. The nitrofen model 
has also provided insights about lung development. The epithelial 
branching process depends on the interaction of the epithelium with the 
surrounding mesenchyme. Collagen type-III and IV, fibronectin and 
laminin are believed to be important regulators of epithelial development. 
Surfactant production by type-II pneumocytes is deficient in CDH.10 
Phosphocholine cyti-dylyl transferase (CTP) is a rate limiting enzyme in 
the synthesis of phosphatidylcholine which is the primary component of 
surfactant. Decreased production of fibroblast pneumocyte factor by lung 
fibroblasts is believed to be responsible for decreased CTP activity in 
fetal type-II pneumocytes (in congenital diaphragmatic hernia fetuses). 
This is responsible for the decrease in phosphatidylcholine synthesis in 
CDH.10 
On day 18 and 19, control lungs and nitrofen exposed lungs look 
similar. The lung volume is however lesser in the nitrofen treated group. 
In the canalicular stage of lung development, the dilated branching 
tubules are less numerous in the nitrofen exposed fetuses with CDH.  The 
saccular stage shows slit like air spaces with thick septa and more type-II 
cells per surface area in the nitrofen exposed lungs as compared to normal 
control lungs. The intra and extracellular multilamellar bodies are 
markers for maturation of type II pneumocytes. In nitrofen exposed lungs, 
these lamellar bodies have an abnormal configuration. 
 
Thus, lung development is affected at an early stage of 
embryogenesis in congenital diaphragmatic hernia and leads to a reduced 
lung volume and weight. There is a reduction in the numbers of 
generations of bronchi and an alteration in the number and function of 
type II pneumocytes. In congenital diaphragmatic hernia, interruption of 
bronchial airway branching occurs around the 10th week of gestation 
when the midgut returns to the abdominal cavity. The ipsilateral lung is 
retarded around the 12th - 14th airway division whereas the contralateral 
lung is affected at the 16th-18th division. 
Pathophysiology of congenital diaphragmatic hernia: 
Areechon and Reid were the first to note reduced bronchiolar 
division in congenital diaphragmatic hernia and this led to the belief that 
pulmonary hypoplasia is directly responsible for the mortality associated 
with CDH.11 The reduced lung volume and functional residual capacity 
are associated with a commensurate reduction in the alveolar surface 
area. The dead space is also increased. 
Many neonates with congenital diaphragmatic hernia demonstrate 
adequate oxygenation for a period of time (called the ‘honeymoon 
period’) before deterioration.  Since pulmonary hypoplasia causes a fixed 
reduction in gas exchange, the 'honeymoon period' cannot be explained, 
Persistent pulmonary hypertension and vascular abnormalities in CDH 
are now believed to be important determinants of outcome, besides the 
pulmonary hypoplasia. 
Pulmonary vascular development in congenital diaphragmatic 
hernia: 
Kitagawa has shown that the number of arterial branches in 
congenital diaphragmatic hernia is  reduced along with an increased wall 
thickness.12 Naeye et al studied a series of 12 patients with CDH and 
noted a significant increase in pulmonary artery muscle mass.13  There is a 
decrease in the overall crossectional area of the pulmonary vascular bed.14 
Geggel et al described the morphometric analysis of pulmonary arteries in 
a series of babies who had died from CDH.15 Three of these patients had a 
honeymoon period before eventual death and 4 had distress at birth and 
could not be resuscitated.  In babies who did not have a honey moon 
period, the muscularization of the arterioles had extended to the level of 
the alveolar ducts. Thus, the pulmonary vascular abnormalities described 
in congenital diaphragmatic hernia are: 
1. Reduced number of conventional and supernumerary arterial 
branches. 
2. Medial hyperplasia of arteries. 
3. Distal muscularizations present till the alveolar duct level. Several 
studies have demonstrated alveolar growth and pulmonary vascular 
remodeling after successful repair of the defect. Beals et al reported 
that in 21 postmortem examination there were changes depending 
on the postnatal age.16 The percentage of intra acinar muscularized 
arteries decreases with age; the lung volume and weight also 
increase.  However, the number of airway generations remains 
constant. 
Fetal and transitional pulmonary circulation: 
There is a dramatic increase in the number and size of pulmonary 
vessels during the second and third trimester of pregnancy. The high 
pulmonary vascular resistance is maintained by relative vasoconstriction 
of the pulmonary vascular bed. 
Transitional circulation: 
At birth there is a sudden decrease in pulmonary vascular resistance 
which leads to a 10-fold increase in pulmonary blood flow. This increases 
the pulmonary venous return to the left atrium and helps in closure of the 
foramen ovale. There is a concomitant increase in the systemic vascular 
resistance which reverses the blood flow in the ductus arteriosus. The 
ductus arteriosus closes (physiologically) in response to increased oxygen 
tension. The stimuli for this transition and fall in pulmonary vascular 
resistance are: (i) Lung expansion and onset of ventilation; (ii) Decrease 
in carbondioxide concentration; and most importantly, (iii) Increase in 
alveolar oxygen tension. 
Persistent pulmonary hypertension (PPHN) in CDH: 
The presence of PPHN in congenital diaphragmatic hernia was 
suspected based on the difference between the pre and postductal arterial 
blood gas values. Cardiac catheterization has confirmed the presence of 
persistent fetal circulation in CDH, In CDH, there is a fixed reduction in 
the cross-sectional area of the pulmonary vascular bed. In addition, this is 
compounded by a variable functional inadequacy of the pulmonary 
vasculature which leads to a further decrease in pulmonary blood flow 
and increases the right to left shunt. The mechanisms which are 
responsible for PPHN in congenital diaphragmatic hernia are: 
Structural factors: 
1. Endothelin 1 is a peptide released from pulmonary endothelial cells 
and causes vasoconstriction via the endothelin A receptor. Kobayashi 
and Puri reported elevation in endothelin 1 levels coinciding with 
clinical episodes of deterioration in CDH infants17.Endothelin may 
play a role in the proliferation of pulmonary vascular smooth muscle 
seen in congenital diaphragmatic hernia. Experimental work is 
presently on to investigate the role of endothelin receptor antagonist 
in PPHN.  Bosentan and BQ-123 are the two known endothelin 
antagonists and both have shown capacity to reduce proliferation of 
vascular smooth muscle. 
2.  TGF- (and insulin like growth factor may also have a role in the 
pathogenesis PPHN ). 
3.  Vasoactive mediators. 
1.  Nitric Oxide: The role of nitric oxide in transitional circulation 
and the etiogenesis of PPHN. Inhaled NO therapy has been used 
clinically in congenital diaphragmatic hernia usually in 
combination with surfactant, ECMO, HFV or perfluorocarbons 
associated gas exchange. Experimental studies have not 
demonstrated an abnormality or deficiency of the NO system in 
CDH. The nitrofen rat model of CDH has however shown a 
significant decrease in nitric oxide synthetase activity. 
2. Prostaglandins: Prostacyclin (PGI2) is a potent vasodilator and 
may play a role in transitional circulation. Leukotrienes C4 and 
D4, thromboxane A2 and PAF are potent vasoconstrictors. An 
imbalance between these mediators may contribute to the 
pathogenesis of PPHN in CDH. Inhibition of prostaglandin 
synthesis has been shown to inhibit the pulmonary vasodilation 
caused by rhythmic distension of the lung. Increased levels of 
plasma thromboxane A2 have been found during episodes of 
pulmonary hypertension in the neonate with congenital 
diaphragmatic hernia. 
Parenchymal factors: 
Surfactant deficiency - Click et al demonstrated that the fetal lamb 
model of CDH was surfactant deficient.10-18 The hypoplastic lungs along 
with the surfactant deficiency leads to barotrauma (interstitial 
emphysema) during overaggressive ventilation. This interstitial air 
trapping further worsens the pulmonary hypertension by compressing the 
pulmonary vessels.  Surfactant therapy decreases pulmonary vascular 
resistance and improves pulmonary blood flow.  
In conclusion, the pathophysiology of CDH involves: 
1.  Pulmonary hypoplasia causing a fixed reduction in the number of 
alveoli available for oxygenation. 
2.  Labile and reactive pulmonary hypertension and persistent fetal 
circulation resulting secondary to vascular smooth muscle 
hyperplasia and vasoactive mediators. 
3.  Surfactant deficiency and overall diminished compliance leading to 
barotrauma and ventilation perfusion mismatch. 
4.  Cardiac dysfunction with lowered cardiac output complicates the 
pulmonary problems.  Relative left ventricular hypoplasia with 
attenuated muscle mass and cavity size have been noted in the fetus 
and neonate.  This cardiac hypoplasia results from poor venous 
return to the left heart.   
Associated Anomalies  
The incidence of associated anomalies in CDH varies between 39% 
and 50%.19,20  The incidence of associated anomalies can be as high as 
95% -100% in stillborn CDH fetuses.  Puri and Gorman noted a high 
incidence of neural tube defects in still born with CDH.21  Sweed and Puri 
analyzed the incidence of associated anomalies in 116 patients with 
congenital diaphragmatic hernia and its impact on survival.2  In patients 
who succumbed during the initial stabilization without surgery (mean age 
11.2 hrs), 63% had associated malformations.  In the other group of 
patients who underwent surgery after stabilization, only 8% had 
associated malformation. 
Cardiac anomalies constitute around 63% of the associated 
anomalies.19,22 Hypoplastic heart and atrial septal defects were the most 
common findings on postmortem examination.  A low postductal PaO2,   
should prompt a search for a hidden cardiac defect.  Ventricular septal 
defects, tetralogy of Fallot, coarctation of aorta and true hypoplastic left 
heart syndrome may be associated.  Cardiac and neural tube defects 
constituted the majority of defects. 
Anatomy of the defect: 
The defect is seen on the left side in around 80% cases.  Bilateral 
defects are rare and only 11 cases have been reported in the literature. 
The size of the defect varies from the usual 2-3 cm to almost a 
completely absent hemidiaphragm.  A rim of muscle is usually present 
around the defect which is more prominent anteriorly.  This rim of 
muscle is not evident posteromedially where it is covered by the 
peritoneum.  A hernial sac is reported in about 20% of patients. 
Clinical Features: 
The onset of symptoms depends on the volume of viscera in the chest 
and the degree of pulmonary hypoplasia. A history of polyhydramnios 
may be noted in upto 80% cases. Prematurity is also noted frequently.  
Immediate presentation: 
The most severely affected babies present with respiratory distress at 
birth. Cyanosis, tachypnea, grunting and retractions are noted on physical  
examination; the abdomen is scaphoid; the  anteroposterior diameter of 
the chest is increased; mediastinal shift can be noted by the presence of 
tracheal deviation and shift of heart sounds; breath sounds are absent on 
the affected side and bowel sounds may be heard in the chest.  
Diagnosis: 
The diagnosis is made on the chest radiograph which shows air filled 
bowel loops in the chest cavity with absence of a visible diaphragmatic 
margin, mediastinal shift and a relative paucity of abdominal gas.  A 
small portion of the ipsilateral lung may be visible superiorly. The 
differentiatial diagnosis of CDH on X-rays includes (i) Congenital cystic 
adenomatoid malformation (CCAM), (ii) Other congenital lung cysts.  
The passage of a nasogastric tube can help in confirming the diagnosis. In 
CCAM, the outline of the lung and the diaphragm can usually be made 
out, mediastinal shift is not marked and normal intestinal gas pattern can 
be seen.  A small amount of dilute barium can be instilled via the 
nasogastric tube to visualize the stomach and see its position relative to 
the diaphragm.  Contrast studies are rarely required.  Ultrasound may be 
helpful in identifying and measuring the diaphragmatic defect.  A cardiac 
echocardiogram is performed to exclude associated congenital heart 
defects, measure the left ventricular mass index and to determine the 
direction of ductal shunting. 
Management: 
A neonate without respiratory distress requires only the passage of a 
nasogastric tube to avoid bowel distension.  On the other hand, neonates 
presenting with distress at birth require intubation and ventilation. The 
medical management of neonates presenting with respiratory distress at 
birth is challenging.  CDH, unlike in the past, is not considered a surgical 
emergency and preoperative stabilization is the primary goal of treatment.  
The surgical aspects of the management are straight forward and 
relatively free from controversies. 
Bag and mask ventilation is contraindicated as it causes bowel 
distension and increases the mediastinal shift. This mediastinal shift 
affects the contralateral lung and also compromises cardiac function.  The 
neonate is nursed in the intensive care with the following general 
measures: 
i.  Maintain normothermia. 
ii.  Intravenous fluids. 
iii.  Nasogastric intubation and drainage. 
iv.  Inotropic support with dopamine and dobutamine may be needed to 
maintain the blood pressure and peripheral circulation . 
Monitoring and blood gas parameters: 
Arterial blood gases are the primary determinants of management 
protcol and prognosis in neonates with CDH. A right radial artery cannula 
is inserted after checking adequacy of the ulnar circulation to monitor the 
preductal blood gases.  An umbilical artery catheter is inserted to monitor 
the postductal blood gas values.  Pre and post ductal pulse oximetry 
probes are used to check the saturation. The hemodynamic status is 
monitored by recording the blood pressure, the heart rate and capillary 
filling time.  The intravenous fluid volume should be enough to maintain 
the perfusion but not excess so as to cause opening of the ductus.  The 
ventilatory parameters are adjusted based on the preductal arterial blood 
gas values.  Boix-Ochoa et al were the first to show a correlation between 
arterial blood gases and outcome.22 They showed that the initial pH 
(mean 6.85) at presentation and the PaCO2 (mean 142 mmHg) at 
presentation was significantly different in non-survivors as compared to 
survivors (pH-7.17, PaCO2 - 60 mmHg). Mishalany et a! used the arterial 
pH on admission in 58 neonates to predict survival – infants with pH>7.2 
at presentation had 100% survival, infants with pH>7.0 had 50% survival 
and infants with pH<7.0 at presentation had only 11% survival.23  The 
various arterial blood gas values used as predictors of outcome in CDH 
neonates are : 
1.  Arterial PaCO2 and pH: Boix-Ochoa et al showed the importance 
of the pH and PaCO2 at presentation and its prognostic 
significance. The significance of a pH value <7.2 and PaCO2>50 
mmHg at presentation was highlighted in other studies as well and 
was an indicator of poor prognosis.  It is important to correlate the 
value of PaCO2 with ventilatory parameters to assess the response 
to therapy. Bohn et al have described the ventilation index (VI) 
as24,47 VI = Ventilatory rate x mean airway pressure.  They 
subsequently correlated the preoperative PaCO2 values with the VI 
and identified three groups of patients.  
(i)  PaCO2 < 40, VI < 1000 – 100% survival. 
(ii)  PaCO2 < 40, VI > 1000 – 38% survival. 
(ili)  PaCO2 > 40, VI > 1000 - <10% survival. 
         This grouping of patients based on the PaCO2 and ventilatory 
parameters has a good predictive value and helps in deciding the timing 
of surgical repair. With the introduction of permissive hypercapnia in the  
management of CDH, the role of PaCO2 in predicting outcome has 
decreased. 
2.  Arterial PO2 (PaO2) : Boix-Ochoa found in 15 neonates that a PaO2 
of <300 mm Hg on a FiO2 of 1.0 was associated with a poor 
prognosis.22 Ruff et al also noted a high mortality associated with a 
PaO2 of <60 mmHg and a pH of <7.2.25 The value of PaO2 
however depends on the site of sampling (pro vs postductal) and 
varies significantly with change in ventilatory parameters. 
3.  Alveolar to arterial oxygen difference (A-aDO2)  
 A-a DO2 = Alveolar PO2 - Arterial PaO2  
 Alveolar PO2 = Inspired PO2 – PaCO2 
Normal neonates on room air maintain a A-aDO2 of <10 mmHg.  
Large gradients are seen in patients with right to left shunting like CDH.  
The ratio of the arterial to alveolar PO2 (a/APO2) is another good 
indicator because it is independent of the concentration of inspired air.  
The normal value of a/APO2 is 0.8.  Harrington et al used A-aDO2 as a 
predictor of outcome after hyperventilation and bicarbonate therapy.26 
They found that in survivors the mean postoperative A-aDO2 was  
319 mmHg as compared to 562 mmHg in non-survivors.  Bohn et al also 
noted that the preductal A-aDO2 in 54 infants with CDH was significantly 
lower in survivors (mean 223 mmHg) as compared with non-survivors 
(mean of 474 mmHg).24  
Timing of Surgery: 
The concept of early surgery in congenital diaphragmatic hernia was 
advocated by Ladd and Gross in the 1940’s.  It was believed at that point 
of time that reduction of the hernia would relieve the lung compression 
and improve oxygenation.  It has now been realized that CDH is far from 
merely a surgical problem.  Cartlidge et al demonstrated a significant 
increase in survival rate from 13% in newborns with CDH operated early 
as compared to 53% survival in newborns operated after stabilization.27 
The Toronto group reported their pre ECMO experience with equivalent 
survival with early (52%) versus late (55%) repair.  There is increasing 
physiologic and clinical justification in delaying surgical repair and 
achieve stabilization. Nakayama et al demonstrated significant 
deterioration in lung compliance following reduction and closure of the 
defect.28 This meant that rather than being beneficial, surgical 
intervention was detrimental in terms of pulmonary compliance and 
oxygenation. Sakai et al also showed that pulmonary compliance 
decreased 10-77% after surgical repair.29 It has also been shown that a fall 
in pulmonary compliance of greater than 50% was associated with a 
100% mortality.  The factors proposed for this fall in compliance after 
surgeries are:  
(i)  Downward displacement and stretching of the diaphragm. 
(ii)  Distortion of the lower chest wall associated with the incorporation 
of the internal oblique muscle in the repair. 
(iii)  Tight abdominal wall closure. 
(iv)  Ipsilateral displacement of the mediastinum causing over 
distension of the contralateral lung. 
A number of studies have assessed the efficacy of the delayed 
approach to the repair of newborn parents with congenital diaphragmatic 
hernia.  These studies varied in their conclusions; in some delayed repair 
was associated with marked increase in survival whereas in others no 
difference was noted.30,31  
Nio et al reported the results of a randomized controlled study and 
could not demonstrate a significant difference in survival rate between 
immediate (12 patients) and delayed repair (18 patients operated >96 
hours) (75% vs 72% survival).52 The results in the same study with the 
use of ECMO showed 67% survival in the group operated immediately 
and 89% in the group which underwent delayed repair. Jaffray ad 
Mackinlay showed an improvement in survival from 45% to 59% with a 
delayed approach.  They also stated that a large number of neonates died 
prior to reaching their surgical centre.  This 'natural selection' in 
congenital diaphragmatic hernia is well known and explains the excellent 
results reported by Gross in the 1940's.  The study by Jaffray et al also 
showed a 37% survival rate in infants born in central hospitals as 
compared to 75% survival in peripheral units.This fact raises the pertinent 
question whether a delayed approach is actually beneficial or helps only 
in the process of natural selection (and hence improves the survival rate). 
The other factor which is probably an important reason for deferred 
surgery is the resolution of PPHN. Haugen et al have used 
echocardiography to determine pulmonary artery pressures in 8 neonates 
with congenital diaphragmatic hernia.33 The pressures at birth ranged 
between 45 - 90 mmHg with evidence of bidirectional or right-to-left 
flow. Pulmonary hypertension resolved after 3 to 20 days (mean of 8 
days) as the pulmonary arterial pressures decreased to 25-55 mmHg.    
Two studies have evaluated the effect of a 'very delayed' approach 
(>72 hours) to repair in CDH.  Wung et al studied the survival rates in 3 
groups of patients: group1 immediate operation  
(6  6 hours); group 2-delayed operation (22  23 hours) and group  
3-very delayed operation (100  44 hours).34 All the patients were 
managed on the principle of permissive hypercapnia.  Survival rates in 
the three groups were 82%, 75% and 94%.  The need for ECMO was 
lesser in group 3 (6%) as compared to group 2 and 1 (25% and 35% 
respectively). Hirschl et al also reported a survival rate of 56% in 66 
patients who underwent delayed repair at 1.2  1.9 days and 68% of these 
patients required ECMO.35 With the very delayed approach (repair at 
mean of 9  5 days), the survival rate significantly increased to 81% and 
the ECMO utilization rate decreased to 33%. 
All the published data suggest that urgent repair does not improve 
survival or gas exchange.  The emphasis of management should be 
directed towards the treatment of PPHN.  Lung compliance studies and 
the gradual resolution of PPHN detailed earlier definitely justify a 
delayed or very delayed approach to repair of CDH.   
Operative Procedure: 
CDH is not a surgical emergency and preoperative stabilization is a 
prerequisite.  Deferred surgery has not in itself increased the survival 
rates, but has helped in selecting survivors from non survivors.  The 
principle steps of the operation are: 
*  Anaesthetic considerations- IV access is required above and below 
the diaphragm; pulse oximetry in pre and post ductal sites; monitor 
BP; use muscle relaxants, narcotics and isoflurane for minimizing 
surgery induced pulmonary hypertension; controlled ventilation using 
high frequency, low tidal volume, pressure limited ventilation. 
*  Transabdominal route used because (i) Easier reduction of viscera by 
the abdominal route, (ii) Accurate visualization of the defect and 
repair possible, without risking injury to gut and other abdominal 
organs, (iii) Can correct any other associated intestinal anomaly or 
perform a Ladd procedure if needed, (iv) Can enlarge the abdomen 
by manual stretching if required or construct a silo.  In case of right 
sided defects, if only the liver is herniated then a transthoracic 
approach is advisable.  In the presence of bowel an abdominal 
approach is used for right sided defects also. 
*  Subcostal incision made 2 cm below rib margin.  Draping should 
allow right chest visualization in case a contralateral pneumothorax 
develops during surgery. 
*  Gentle reduction of viscera with liver and spleen last, use of a Red 
rubber catheter to equalize the intrathoracic pressure facilitates 
reduction of viscera.  
*  Identify the rolled posterior diaphragmatic rim and dissection of the 
pleural- peritoneal fold to release the posterior rim. 
*  Closure of the defect by a single layer horizontal mattress non-
absorbable suture starting medially.  For large defects the options 
are-synthetic mesh repair, intercostal muscle flaps, internal oblique 
and transversus abdominis flaps, rectus abdominis flaps, reversed 
latissmus dorsi flaps.  
*  Additional procedures like Ladd procedure performed if the patient is 
stable. 
*  Abdominal wall closure only after ensuring that respiration is not 
effected.  If closure is under tension then the options are-skin closure 
only, patch repair or construction of a silo. 
*  Right sided defects - The reduction of the liver should be done with 
careful hemodynamic monitoring because kinking of the hepatic vein 
or vena cava can occur causing a decrease in venous return. Careful 
dissection of the fibrous attachments of the vena cava to the medial 
side of the defect will help in reduction. Also the liver is very friable 
and soft and can be easily traumatized. 
 
Use of Chest Drainage: 
The use of prophylactic chest drainage after the repair of CDH is 
controversial.  Pulmonary barotrauma depends on the peak inspiratory 
pressure and the transpulmonary pressure gradient (TPG). Ipsilateral 
chest drainage increases the TPG and therefore increases the incidence of 
barotrauma. The small pocket of air which remains after repair of the 
defect and no chest drainage acts as a protective cushion by decreasing 
the TPG.  Air leaks cause hypoxia, acidosis and exacerbate the 
pulmonary hypertension.   
Adjunctive Therapies: 
Extracorporeal Membrane Oxygenation (ECMO) 
The induction of ECMO since the early 1980's led to a tremendous 
enthusiasm regarding its use in neonates with congenital diaphragmatic 
hernia.  It was believed that ECMO would help in tiding over the period 
of time required for postnatal vascular remodelling. However, the ELSO 
registry data has shown that of all babies with acute respiratory failure 
requiring ECMO, the worst outcome is in babies with CDH.39 A 58% 
survival rate, compared with an overall survival of more than 81% has 
remained essentially unchanged over the past 10 years. 
ECMO is an invasive procedure which is expensive and associated 
with significant risks.  The initial selection criteria were based on 
predictors of high mortality rate (>80%) in newborns with congenital 
diaphragmatic hernia.  Individual centres with ECMO facility have used 
their own set of criteria for instituting ECMO in neonates with congenital 
diaphragmatic hernia.  The various criteria used in the series reported are: 
1. Alveolar to arterial oxygen difference (A-aDO2) - The A-a DO2 
level of >600 for a duration of 8 hours has been used as a predictor 
of high mortality and need for ECMO  support.40, 43 
2. Oxygenation index (OI = MAP x FiO2 x 100 (PaO2) : The OI 
criteria have also varied but in general a OI value of >40 for 2-3 
hours suggests the use of ECMO.40,41 Butt et al suggest that ECMO 
should be offered to congenital diaphragmatic hernia patients with 
an OI above 30.43 
3. Other criteria - Preductal PaO2, ventilation index, pulmonary 
compliance, percentage of nucleated red blood cells, clinical 
evidence of deterioration or pulmonary barotrauma.   
The idea behind these selection criteria is to avoid offering treatment 
to neonates with fatal pulmonary hypoplasia.  The problem lies in the fact 
that there is till date no absolute criteria which can predict irreversible 
fatal pulmonary hypoplasia.  It is also known that neonates may sustain 
severe lung injury using conventional ventilation.  This has led to a trend 
of offering ECMO support earlier in congenital diaphragmatic hernia to 
avoid this iatrogenic lung injury. A brief 'honeymoon period' of adequate 
duration is a good indicator of sufficient pulmonary reserve and such 
patients may benefit from ECMO. 
Timing and duration of ECMO: 
ECMO support can be provided before repair of the defect or after 
the repair.  With the advent of delayed repair more infants are being 
placed on ECMO preoperatively, in the hope of achieving stabilization.  
The incidence of hemorrhagic complications is high with repair on 
ECMO and the mortality rate in this group of patients is high.  The 
operative procedure for patients on ECMO has been modified to decrease 
the incidence of hemorrhagic complications44 - (i) use of perioperative 
aminocaproic acid, (ii) liberal use of electrocautery and meticulous 
hemostasis, (iii) application of fibrin glue, (iv) liberal use of Gore-Tex 
patch repair instead of extensive dissection, (v) avoid stretching of the 
abdominal wall and resorting to a silo pouch if needed.  Recurrent hernia 
is common after the repair of congenital diaphragmatic hernia on ECMO 
and can be seen in upto 50% patients.45 Ideally, surgery should be 
avoided while the patient is on ECMO. 
Weaning from ECMO may take days and currently the mean time on 
ECMO for patients with CDH is 191 hours.39 The ELSO national registry 
data also suggests that survival is significantly decreased when more than 
two weeks of ECMO support is required.  In general, an ECMO course of 
more than 14 days is usually not required.  There is also a risk of 
recurrent hypoxemia and pulmonary hypertension after weaning from 
ECMO support.  It is advisable to leave the neck cannula in place for 
several days after discontinuing ECMO, with continued heparin infusion 
to keep the line patent.  
Venovenous ECMO is preferred over venoarterial ECMO; the carotid 
artery does not need to be ligated, pulsatile flow can be maintained and 
myocardial oxygen delivery is better.  Heiss et al found that venovenous 
bypass was as effective as venoarterial ECMO.46 The other problem with 
ECMO in congenital diaphragmatic hernia is the difficulty in achieving 
proper cannula placement.  
Results of ECMO in CDH: 
The multitude of retrospective studies using ECMO in neonates with 
CDH have in general reported an improvement in survival rate.48,49,50  The 
problem in evaluating the results is most series are small, retrospective 
studies and use different selection criteria. Also, during the same period 
other management strategies were simultaneously introduced and 
therefore the true impact of ECMO on the survival rate in high risk CDH 
babies is not established. Survival rates of 38% to 65% have been 
reported with the use of ECMO in high risk infants with congenital 
diaphragmatic hernia. 
O'Rourke et al in a study reported a 51% mortality rate in severe 
congenital diaphragmatic hernia between 1984 and 1987 with the use of 
ECMO.51 Before the introduction of ECMO, the mortality rate at their 
institution was 53%. In two studies from Toronto and Boston covering a 
period of 14 years survival rates of 52% and 53% were reported. In the 
Toronto series, the survival rate of around 50% has remained unchanged 
despite the use of high frequency ventilation. In the Boston series, which 
has used ECMO as a rescue therapy (instead of HFV), the survival rates 
have only increased in the most recent period (1991-1994) with the use of 
pressure limited, permissive hypercapnia ventilation. There is a broad 
opinion that ECMO does improve the outcome in congenital 
diaphragmatic hernia. The other important issue with the use of ECMO is 
the morbidity and long term complications of the procedure. The long 
term effects associated with the use of ECMO is detailed later. 
The present view is in favour of late surgical repair and the use of 
ECMO in congenital diaphragmatic hernia is beginning to decrease, 
either because of disillusionment or because of the success of alternative 
therapies. At the present time, ECMO in CDH should be reserved for 
infants with severe PPHN who fail to respond to the alternative 
modalities available.  
High Frequency Ventilation: 
High frequency positive pressure ventilation (HFPPV) is defined as 
the use of positive pressure ventilation with respiratory rates in the range 
of 100-150 breaths/min. The airway pressure is kept less than 30 cm H20 
to reduce barotrauma whereas the rate is increased to improve gas 
exchange and decrease PaCO2. High frequency ventilation (HFV) is 
different from HFPPV, and uses rates in excess of 1 / second with tidal 
volumes lesser than dead space ventilation. The two modes of HFV in use 
presently are: (i) High frequency oscillation ventilation (HFOV) - HFOV 
uses a piston with an oscillating diaphragm which produces a high 
frequency (5-15 Hz) sine wave which is applied to the airway via a T-
piece system. Expiration is active in this system and does not rely on lung 
recoil, (ii) High frequency jet ventilation (HFJV) - This system uses a 
high pressure gas, source with flow interruption which delivers small 
tidal volumes via a catheter in the airway at frequencies of 1-5 Hz. 
Expiration is passive in this system. 
HFOV has demonstrated the ability to reduce PaCO2 and induce 
alkalosis in the presence of significant pulmonary hypoplasia.  They have 
found a rapid reduction in the PaCO2 whereas the improvement in PaO2 
was temporary and not sustained beyond 24 hours. The initial 
improvement in the PaO2 is probably due to the improvement in pH and a 
decrease in the right to left ductal shunting. There were 5 survivors in this 
group of infants where the expected mortality was 100%. The results of 
other series have also reported a reduction in the PaCO2 levels with HFV 
but could not demonstrate an increase in survival.52, 53 With the present 
focus on permissive hypercapnia, the use of HFV to achieve reduction in 
PaCO2 levels is obsolete. Bohn et al have shown that in 87 infants in 
whom HFOV was used (after failure of conventional ventilation), the 
overall survival was only 11%.  The improvement in PaCO2 and PaO2 is 
seen consistently but is frequently unsustained. 
Surfactant Therapy: 
The role of surfactant therapy in neonates with hyaline membrane 
disease has been established. The surface tension forces at the alveolar 
level are reduced with the administration of surfactant, which reduces the 
tendency for alveolar collapse and improves ventilation at lower peak 
airway pressures. Studies have documented a relative surfactant 
deficiency in CDH patients based on a low lecithin/ sphingomyelin ratio 
seen during fetal life. Click et al have shown in the surgically created 
lamb model of CDH that there is a reduced level of phosphatidyl choline 
and increased protein content in lung lavage fluid.10 Proteins within the 
alveoli are known to inhibit surfactant activity and this is in addition to 
the insufficient surfactant production. In a separate study, Click and 
coworkers in a series of controlled animal studies, administered 
exogenous bovine surfactant into the endotracheal tube immediately after 
delivery.54 They showed a significant improvement in functional residual 
capacity, lung compliance and PaO2 within 30 minutes of surfactant 
administration as compared with control animals. They also demonstrated 
in a later study that this improvement was sustained till 4 hours post 
administration and there was an increase in pulmonary blood flow. Suen 
et al showed that steroid therapy enhanced the endogenous surfactant 
production in the Nitrofen induced rat model of congenital diaphragmatic 
hernia.  
 
Inhaled Nitric Oxide (INO) Administration: 
Nitric oxide is an endogenous molecule that induces production of 
CGMP and causes relaxation of vascular smooth muscle. NO has been 
identified as the endothelial- derived relaxing factor. The role of NO as a 
highly selective pulmonary vasodilator led to its use in the treatment of 
PPHN. Animal studies have shown that endogenous NO modulates the 
pulmonary vascular tone in the fetus during late gestation. The pulmonary 
vasodilatation produced by oxygen and lung expansion in the immediate 
newborn period is also believed to be secondary to endogenous NO. 
Initial studies have demonstrated that administration of INO to full term 
infants with PPHN resulted in an increase in SaO2 in almost all   
patients.57 58 59 
A prospective, randomized, multicentre study has been performed to 
evaluate INO therapy in fullterm neonates with respiratory insufficiency 
(Kinsella et al). This study has compared the efficacy of HFOV with INO 
in patients who demonstrated a PaO2 of < 60 mmHg on FiO2 1.0. Only 
10% of the 33 patients with CDH responded to HFOV, 10% to INO and 
5% to the combination of both HFOV and INO. The results of INO 
therapy have been inconsistent and most reported trials are small 
uncontrolled series.  Inhaled NO can decrease the right to left shunting in 
infants who have PPHN and improve oxygenation but will not alter the 
outcome in patients with severe pulmonary hypoplasia. Karamanoukian 
et al evaluated the efficacy of INO (80 ppm dose) in 8 neonates with 
CDH.58 No improvement was noted in the postductal PaO2.  However, 
oxygenation was improved when INO was administered after 
decannulation from ECMO. Shah et al demonstrated a temporary increase 
in postductal PaO2 in response to 5-10 ppm INO therapy.59 
Administration of surfactant and / or perfluorocarbon may enhance the 
effect of INO in patients with CDH. Karamanoukian has shown that 
newborn lambs receiving surfactant and INO had a higher pH and PaO2 
and lower PaCO2 than control lambs who received only INO.61 The other 
problem with the use of INO besides the inconsistent response has been 
the rebound hypertension which is seen after discontinuation. Patients 
who are NO dependent should have the gas continued during surgical 
repair. 
The other approach has been the attempt to enhance the effect of the 
endogenous NO. NO produces vasodilatation via CGMP which in turn is 
inactivated by CGMP phosphodiesterase. Two phosphodiesterase 
inhibitors, dipyridamole and zaprinast have been used in animal studies. 
These agents can augment the effect of INO in neonates with CDH and 
also reduce the INO dose required. A reduced INO dose can decrease the 
incidence of rebound hypertension after discontinuation of therapy. 
Liquid Ventilation 35: 
The discovery of flurocarbons led to the feasibility of liquid 
ventilation. Liquid ventilation was propounded because liquid spreads 
more uniformly in the lung and the liquid filled alveoli have much 
diminished surface tension forces. Perfluorocarbons are clear, colourless 
and odourless fluids which have the following properties-(i) Chemically 
and physiologically inert, (ii) Greater solubility for respiratory gases than 
blood (50 ml 02/dl), (iii) Low surface tension (19 dynes/cm), (iv) Dense 
fluid (1.9 g/ml), (v) Low vapor pressure hence eliminated by 
vaporization, (vi) Can be made radio-opaque by adding a terminal 
bromide molecule.  
Two methods of perfluorocarbon assisted ventilation have been 
described- 
i. Total liquid ventilation (TLV)-The lung is filled to total lung capacity 
with perfluoro carbon. Because of the high viscosity of the fluid, the 
perfluoro carbon has to be 'expired' in and out of the lung and 
oxygenated. This requires very complex circuitry equipment and 
hence has limited clinical use. 
ii. Partial liquid ventilation (PL V) - This technique uses gas ventilation 
with conventional settings with the lungs filled with a volume of 
perfluoro carban equal to the functional residual capacity (15 ml / 
kg). 
Major et al evaluated gas exchange in 8 full term newborn lambs 
with surgically created CDH – four underwent conventional mechanical 
ventilation and four underwent PLV.61 The pH, pulmonary compliance 
and PaCO2 showed improvement in the PLV group. Pranikoff et al used 
PLV in four infants with CDH on ECMO and noted improved PaO2 and 
pulmonary compliance.62 Of these 4 patients, two survived and one 
patient developed pulmonary hemorrhage. Currently trials are on to 
evaluate the safety and efficacy of PLV with perfluorocarbons in 
newborns with CDH who demonstrate an oxygenation index between 10 
and 30. Fauza et al have shown an increase in alveolar number and size in 
lambs subjected to postnatal lung distension wth perfluorocarbon.63 
Intravenous Pulmonary Vasodilators: 
The 1970's saw a deluge of pulmonary vasodilators being used for 
the treatment of pulmonary hypertension associated with CDH. However, 
none of the agents were selective pulmonary vasodilators, and all 
produced simultaneous systemic hypotension.  This exacerbates the 
extrapulmonary right to left shunt and worsens the hypoxaemia. 
Intravenous pulmonary vasodilators may also cause ventilation- perfusion 
mismatch. Tolazoline is an alpha-blocker and also releases histamine 
from tissues to induce vasodilatation, Tolazoline also has chohnomimetic 
properties and inhibits synthesis of the vasoconstrictor thromboxane A2. 
The side effects of Tolazoline (oliguria, hypotension, gastrointestinal 
bleed, thrombocytopenia, seizures) and its unpredictable effect led to the 
discontinuation of its use. Prostacyclin can cause a lowering of the A-
aDO2 and OI values after infusion in high risk CDH patients with PPHN, 
but does not alter the overall outcome.14 The mean arterial blood pressure 
is not effected, but prostacyclin causes an increase in the bleeding time. 
Prostaglandin D2 (PGD2) causes a variable decrease in the pulmonary 
artery pressure and improves oxygenation in PPHN. Systemic 
hypotension is seen with PGD2 infusion. Various other vasodilators like 
nitroprusside, chlorpromazine, isoprenaline, glucagon and halothane have 
been used but the results are inconsistent and the associated problems 
offset the advantages.  
 
Lung Transplantation: 
The experience with lung transplantation in newborn infants is 
limited; Starnes et al have reported their experience in 5 infants with 3 
survivors65 The use of reduced size lung grafts from living donors is 
being investigated. The left lower lobe or the right middle lobe can be 
used. In patients with CDH, an ipsilateral lung transplant can be used 
temporarily till the contralateral lung matures and PPHN resolves. The 
transplanted lung can then be excised and immunosuppression 
discontinued. There is a single report of one patient with CDH who has 
undergone lung transplantation.66 This patient with right CDH, received a 
right middle lobe from a newborn donor and is doing well on follow up at 
2 years of age. Lung transplantation is a promising option for newborns 
with CDH and severe pulmonary hypoplasia. The known complications 
of lung transplantation include delayed somatic growth, risk of infection, 
lymphoproliferative diseases and obliterative bronchiolitis. 
Prognostic Factors: 
(A) Antenatal 
1. Polyhydramnios - Kitagawa et al suggested that infants born to 
mothers with polyhydramnios have a 11% chance of survival as 
compared with the 55% survival without polyhydramnios.  
2. Gestational age less than 25 weeks at diagnosis has been shown 
to be a poor prognostic factor.67 
3. Presence of an intrathoracic stomach – The presence of stomach 
in the chest on antenatal ultrasonography is associated with 71% 
mortality as compared to 7% mortality if the stomach was below 
the diaphragm.68 
4. Small lung to thoracic transverse ratio (L/T ratio) - The L/T ratio 
predicts the degree of hypoplasia and predicts outcome. 
5.  Low left ventricular mass - The presence of a cardiac anomaly 
(seen in 30% fetuses) was shown to be universally fatal in a large 
series from Boston. Fetal cardiac ventricular disproportion in the 
form of reduced left / right ventricular size before 24 weeks 
gestation has an associated mortality of nearly 100%. 
6.  Contralateral lung to head circumference ratio - The ratio of the 
right lung area (two dimensional area at the level of the atria) to 
head circumference (LHR) predicts outcome. In a series of 55 
cases, a LHR ratio of less than 0.6 was predictive of 100% 
mortality. LHR > 1.35 predicted survival independent of liver 
position or gestational age at time of diagnosis. 
7.  Chromosomal anomalies and other associated anomalies are 
associated with poor prognosis.70 Puri et al have shown that 
100% of stillborns with CDH have major associated anomalies,3 
Harrison et al have suggested that cases diagnosed before 25 weeks 
gestation with a small LHR and liver herniation into the chest are 
associated with the poorest prognosis.67 
(B) Postnatal Prognostic Factors 
(1) Blood gases 
i. pH < 7.2 and PaCO2 > 50 mmHg is associated with poor prognosis 
(in the era before the concept of permissive hypercapnia was 
introduced).  
ii. Pulmonary function studies - Antunes et al evaluated the oxygen 
index and functional residual capacity in CDH survivors.69 All 
nonsurviving infants had preoperative functional residual capacity 
of less than 9 ml / kg. On the other hand, only 2 of 15 survivors 
had preoperative functional residual capacity of less than 9 ml/kg. 
iii. Echocardiographic findings - Studies have shown that left ventricular 
mass of less than 2g/kg is predictive of 100% mortality. Also it has 
been shown that in patients operated on ECMO if the cardiac angle 
(normal value of 45o) did not return to normal after repair, all such 
neonates did not survive. Dilatation of the pulmonary artery 
relative to aortic narrowing suggests an impaired left ventricular 
output. Patients with this abnormal feature died despite ECMO 
support and surgical intervention.  
iv. Side of defect - Right sided defects has a poorer prognosis. Bilateral 
hernias also have a poor prognosis. 
v. Timing of presentation - The mortality rate in infants presenting 
within 6 hours of birth is high as compared to the almost negligible 
mortality seen in infants presenting after the first day of life. 
Fetal Diagnosis and Therapy: 
Antenatal diagnosis of CDH by ultrasonography was described 
towards the end of the 1970's. This led to the need for identifying reliable 
prognostic factors antenatally so that proper counselling could be given. 
1. Maternal serum alpha-fetoprotein (MS-AFP): 
MS – AFP can be detected from the 12th week of gestation and it 
steadily increases in concentration to peak between week 30-32 low 
levels of MS – AFP have been identified in CDH, trisomy 21 and trisomy 
18. 
2. Ultrasonography: 
 
The gold standard for antenatal diagnosis of CDH is now a level 3 
ultrasound examination. The features which indicate CDH in a fetus are : 
(i) Polyhydramnios (seen in 80% of fetuses with CDH). 
(ii) Absent or intrathoracic stomach bubble. 
(iii) Mediastinal shift. 
(iv) Presence of abdominal viscera in a transverse scan at the level of 
a four chamber view of the heart. 
(v) In extreme cases, fetal hydrops. 
(vi) Associated anomalies like cardiac defects, neural tube defects. 
False positive diagnosis of CDH by ultrasound is rare.  
3. Chromosomal analysis: 
The chromosomal anomalies associated with CDH include trisomy 
18 and 13, 3p microdeletion and 12p tetrasomy. Amniocentesis is the 
usual method of obtaining fetal cells for chromosomal analysis. 
Fetal Therapy: 
Although there have been rapid innovations in the postnatal 
management of CDH, the 'hidden mortality' is an important factor in the 
postnatal outcome of antenatallv diagnosed fetuses with CDH. In a 
prospective study, Harrison et al showed that in 83 fetuses with isolated 
CDH diagnosed before 25 weeks of gestation, 58% died despite care in a 
centre equipped with ECMO.67 Experimental studies have shown that 
after creation of CDH early in gestation and subsequent repair, the lung 
volume improved and the pulmonary arteriolar muscle hyperplasia 
resolved.9,71 The selection criteria for fetuses for prenatal therapy is based 
on identifying antenatal ultrasonographic features associated with poor 
outcome - diagnosis before 24 weeks gestation, fetal cardiac ventricular 
disproportion, contralateral lung to head circumference ratio and liver 
herniation. 
The options available for in-utero intervention in CDH are 72-73. 
1. Complete in utero repair - This technique is applicable for fetuses 
that do not have liver herniation. The 'two-step' technique described 
by Harnson et al is used.74 A thoractomy and a sub costral incision 
are used to reduce the viscera by a ‘push – pull’ technique.  The 
diaphragm is reconstructed using a Goretex patch and the abdominal 
cavity is enlarged by a similar Goretex patch. Color doppler imaging 
is used to define the position of the portal venous structures and the 
course of the umbilical vein which would indicate whether the liver 
is herniated or not. Direct repair of fetal CDH is possible and has 
achieved favourable result.75  It has been shown that the overall 
mortality in 'liver-down' CDH is low in both the fetal surgery group 
as well as the postnatal treatment group. These patients have a more 
benign course, regardless of treatment and therefore the maternal 
risks associated with fetal surgery do not justify in-utero intervention. 
2. PLUG Technique - The early attempts at reduction of CDH in fetuses 
with liver herniation showed that open surgery was uniformly 
unsuccessful. The reduction of the liver back into the abdomen 
results in acute obstruction of the ductus venosus and the reduced 
umbilical venous return led to fetal death. Experimental work has 
shown that fetal tracheal obstruction can correct the pulmonary 
hypoplasia associated with CDH.76 Tracheal obstruction expands the 
fetal lung by preventing drainage of fetal lung fluid and this in turn 
pushes the viscera back into the abdomen. Harrison et al developed a 
procedure of temporary tracheal occlusion and called it the PLUG 
(Plug the Lung Until it Grows).77 The EXIT procedure (Exutero 
intrapartum tracheoplasty) was developed to maintain the 
fetoplacental circulation while the fetal airway was secured. The fetal 
head and shoulders are delivered and the umbilical cord is 
maintained. The external clip is removed with bronchoscopic 
monitoring and the trachea is evaluated for any possible damage. The 
baby is intubated and surfactant is administered. Once the airway is 
secured, the umbilical cord is divided. Though this technique of 
PLUG followed by EXIT is promising, complications encountered 
during the evolution of this strategy have limited survival. There is 
also evidence that tracheal obstruction may delay or depress 
pulmonary maturation and surfactant production. 
3. Fetendo plug78 – Video assisted fetal endoscopy (fetendo) avoids the 
hysterotomy needed for fetal exposure and decreases the risks of 
preterm labor.  Harrison et al has described a two-trocar 
videofetoscopic PLUG technique.  
Results 
(A) Mortality 
In 1946, Gross reported a series of 63 infants with CDH with  
55 survivors.   Since these, despite the advances in pediatric surgery, 
anaesthesia and intensive care, no subsequent series has achieved such a 
high survival.  The law of natural selection was responsible for this 
aberrant fact, because the most severely asphyxiated infants died before 
being referred for treatment. 
The mortality in newborn infants with CDH presenting in the first 6 
hours of life remains between  40-50. Infants who have symptoms after 
24 hours of life have nearly a 100% chance of survival.  In an analysis of  
30 series documenting outcome in 2024 new borns with CDH, Langham 
et al reported that there were 1244 survivors, an overall survival of 0.60 
(95% confidence intervals, 0.55 – 0.65%).79   There is a wide variation in 
the presentation, associated anomalies and treatment modalities used in 
these series.   The mortality is higher if CDH is diagnosed antenatally and 
most series report figures between 56-86%. 
Long Term Results: 
A. Cardiopulmonary consequences 
In the acute phase associated cardiac anomalies, left ventricular 
hypoplasia and cardiac 'stun' associated with ECMO effect outcome. 
However, the long term cardiac effects in infants with isolated CDH are 
minimal.  
Pulmonary consequences have been investigated in detail, Chartrath 
et al in 1971 described X-ray and pulmonary function tests in survivors of 
CDH.80   Three of 5 infants had normal X-rays and two demonstrated 
emphysematous changes.  The FEV1 and FVC were significantly lower 
for CDH patients.   Wohl et al reported normal FEV1, FVC and other 
parameters in 19 survivors of CDH aged 6-18 years.81 However, 
pulmonary blood flow was reduced to the ipsilateral side in all the cases.  
It has been shown in ventilation-perfusion radionuclide studies that 
ventilation is essentially equal between lungs but the perfusion is more to 
the contralateral side (ipsilateral is approximately half of the contralateral 
lung).  Despite this most studies report normal exercise tolerance in 
survivors.82  
  The study by Vacanti et al discussed the pulmonary follow-up in 
CDH survivors treated with ECMO and reported 65% mortality 
secondary to complications of chronic ventilator support.   The study by 
Nagaya et al examined two groups of CDH survivors.83  Patients who did 
not require ECMO support had matched ventilation and perfusion in both 
the lungs.   The neonates who had compromised gas exchange and 
required ECMO had significantly decreased ipsilateral ventilation and 
perfusion.  Over a period of 44 months, ipsilateral lung ventilation 
increased to 88% of the contralateral lung while the perfusion remained 
nearly fixed.  Koumbourlis et al reported that in survivors of CDH there 
is a catch up growth during the first 2 years with an increase in the FRC.84 
This was associated with improved lung compliance.  The associated 
skeletal abnormalities seen in CDH patients also compromise lung 
growth. 
The incidence of chronic respiratory problems is also high in CDH 
survivors, especially in those managed with ECMO.  Bernbaum noted 
bronchopulmonarv dysplasia in 50% of CDH survivors managed with 
ECMO.85  Recurrent respiratory infections and repeated hospitalization 
for chronic respiratory problems are common early in follow-up but the 
pulmonary status tends to improve with time. 
B. Recurrent herniation: 
Recurrent CDH is seen in 2-22% cases and diagnosed by CXR or 
contrast radiography.  Van Meurs et al showed a 22% recurrence rate for 
primary repair and a 40% recurrence rate for patch repair. 
Gastrointestinal problems: 
Foregut dysmotility is common in CDH survivors and probably 
results secondary to extrinsic pressure on the developing esophagus by 
the herniated viscera.  The extrinsic pressure may lead to intrauterine 
dilatation of the esophagus which can impair motility.  Also, the length of 
the intra abdominal esophagus is short and the angle of His is altered. The 
perihiatal diaphragm is deficient and can lead to a hiatal hernia.  The 
stomach is frequently nonrotated and this accounts for the associated 
delayed gastric emptying.  Stolar et al were the first to note esophageal 
functional and anatomical abnormalities in CDH survivors.87   
The incidence of symptomatic GER varies between 17-26% and upto 
36% of CDH patients require operative intervention in  
follow-up.85-90   Vanamo et al evaluated 60 survivors of CDH and reported 
that 18% infants developed early symptoms of GER.89 At late follow-up 
(mean- followup of 29.6 years), 63% of the patients still had symptoms 
suggestive of GER and 54% had histological or endoscopic evidence of 
esophagitis.  The etiology of GER in CDH has been explained by-  
It is important to look for GER in survivors of CDH who have failure 
to thrive, recurrent respiratory problems or gastrointestinal symptoms.  
Medical management of GER and prokinetic agents for improving gastric 
emptying should be instituted early. 
The incidence of adhesive intestinal obstruction in survivors of CDH 
is around 10%.  Inherent malrotation associated with CDH may also 
predispose to obstruction. 
C. Growth and development 
Failure to thrive has been noted in many survivors of CDH. Van 
Meurs et al reported that 50% of ECMO treated CDH survivors were less 
than the 5th percentile for weight at 1 and 2 years of age.86  Most reports 
show that 30-40% of CDH infants are below the 5th percentile for age 
after 2 years.90-92 
MATERIAL AND METHODS 
 All  cases of congenital diaphragmatic hernia admitted in Govt. 
Rajaji Hospital, Madurai were studied. 
 All cases were given adequate preoperative preparation and those 
surgically treated were followed up for a period of  1 year  and 
their outcome was noted. 
 Those cases which were not eligible for surgical treatment were 
analyzed and their outcome was noted. 
 
 
 
 
 
 
 
 
OBSERVATION & RESULTS 
Preoperative Work up:  
All the 60 new borns that were included in the study were 
thoroughly evaluated.  which included  
1. Antenatal History  
2.  Birth History 
3. Immediate Postnatal period  
4. Through physical examination  
5. SpO2 status 
6. Echo Cardiogram 
7. X-Ray chest  
a. AP view 
b. Lateral   view 
8. Ventilator support  
After examination and initial evaluation all the new borns were nursed 
in the neonatal intensive care unit.  Children with severe respiratory 
distress  were electively ventilated.  T. Sildenafil was used at the dose of 
1mg/kg every 8th hourly to reduce the persistent respiratory distress.    
Children who became stable were extubated and subjected to surgery.  
Echo cardiogram and severe distress were used as criteria for ventilatory 
support.  
1. Antenatal History  
All babies that were born in the hospital & referred from outside, a 
through antenatal history was obtained for. 
a. Antenatal Detection of Diaphragmatic Hernia  
 
Yes 35 
No 25 
 
 
 
 
Antenatal Detection of Diaphragmatic Hernia  
a. Week of Pregnancy at which Defect was Deducted 
 
Before 24 weeks of Gestation 10 
After 24 weeks of Gestation 15 
 
 
 
2. Birth History  
Normal Vaginal Delivery 35 
LSCS 25 
      
 
 
   
Indication for LSCS 
Repeat Section 17 
Maternal Cause / Fetal Distress 8 
 
3. Immediate Postnatal Period: 
APGAR scores of all babies born in the hospital were noted. Any 
cyanosis at birth was identified which played an important role in the 
outcome of the surgery.  
a.Cyanosis at Birth  
Hospital Birth 
Cyanosis at Birth 12 
No Cyanosis 36 
n = 44 
 
  
Delivered Outside   
Cyanosis 13 
No cyanosis 3 
 
n =16 
 
 
 
 
 
 
 
4.Ventilatory Support: 
 
Required Not Required 
22 38 
 
Ventilatory Support: 
 
n = 60 
 
 
 
 
 
Number Weaned/ 
Underwent Surgery 
Number Could not be weaned 
from ventilator 
8 14 
 
 
n = 22 
 
5.Physical Examination: 
No  obvious skeletal defects or any other defects were seen in our 
group. 
 
 
 
 
6.SpO2  Status: 
All the 44 babies born in Govt. Rajaji Hospital, Madurai were 
evaluated for Spo2   using pulseoxymeter. 
The 16 out born babies could not be evaluated. 
SpO2 Status 
Below 80% Above 90% Total 
8 36 44 
 
 
n = 44 
 
 
 
7.ECHO Cardiogram: 
Since Echo Cardiogram facility was available at a distant location 
from new born facility eight children were too sick to be shifted to 
undergo the study. 
 
No. Patients under went ECHO 52 
Did not undergo ECHO 8 
 
 
n = 52 
 
Results of ECHO Cardiogram  
Cardiac defect  Pulmonary Hypertension  
Present Absent Mild to Moderate Severe 
ASD VSD 
40 22 8 10 
(small) 2 
 
 
Pulmonary Hypertension 
 
Surgical Procedure: 
 All the patients who were stable after adequate pre operative 
preparation were taken up for surgery. 
  
No. patients taken up surgery  - 38 
Left side Hernia Right side Hernia 
35 3 
  
 
 
 
 
 
 For all left sided hernias a left side subcostal incision was 
preferred, in case of right   side hernia right postero lateral 
thorocotomy was done. 
 All the left sided hernia that were operated were found to be 
Bochdalek type. 
 No associated malrotation or  bowel duplication were seen. 
 All the children are being followed up for 1 year post operative 
period. 
 
Total no.of patients operated  - 38 
Survival Mortality 
36 2 
  
 
Overall Survival and Mortality: 
Total No. of patients in the study  - 60 
Survival Mortality 
36 24 
   
 
Total No. of patients - 60 
Deaths - 24 Survived following 
surgery  Surgery 
and Death 
Ventilated and 
could not be 
weaned 
Too sick for 
aggressive 
resuscitation 
2 16 6 36 
 
Post operative follow up :- 
1. 2 patients had post operative adhesive obstruction for which 
adhesion release was done. 
2. 1 patient developed post operative incisional hernia. 
DISCUSSION 
The results of surgical repair of diaphragmatic hernia depended 
largely on the preoperative stabilization and type of cases admitted to the 
hospital.  
Late surgical intervention with adequate preoperative surgical 
preparation has significantly improved the survival rate in patients who 
under went surgical repair as seen in our study.  
Antenatal detection of Congenital Diaphragmatic Hernia helps in 
delivering such babies at centers that can treat Congenital Diaphragmatic 
Hernia. Antenatal scan also acts as one of the prognostic indicators in 
baby that were diagnosed to have congenital diaphragmatic hernia. 
Antenatal detection before 24 weeks of gestation carries poor prognosis 
as opposed to those that were diagnosed after 24 weeks and was 
confirmed by our study.  
Use of sildenafil 1mg/kg/8hrs was used in patient who had severe 
respiratory distress and persistent pulmonary hypertension.  Sildenafil 
therapy was given for 3 – 5 day depending upon their clinical 
improvement which was also confirmed by Echo Cardiogram before 
taking up for surgery.   
Out of 22 patients who required preoperative ventilation due to 
severe respiratory compromise, 14 could not been weaned from 
ventilatory support and eventually succumbed to the disease process. 
Only 8 patients were weaned from ventilator and taken up surgery.     
Those patients who were taken up for surgery were assessed under 
ASA IV.  In our series left side hernias (92%) were more than right sided 
hernias (8%).  Left side sub costal incision was preferred since it was 
easier to reduce the contents and to look for any associated malrotation 
and duplication of bowel.  
All the left side hernias that we operated were of the Bochdalek 
type of hernia with spleen and intestine as common contents .Out of 35 
babies, 5 had entire bowel, Spleen and stomach inside the left hemi 
thorax. In all babies diaphragmatic repair was possible with out the use of 
any prosthetic material. Primary abdominal was closure was possible in 
all but one baby in which a ventral hernia was created.  
In case of right side hernia, right side lateral thorocotomy was 
preferred.  Liver was the primary content which required reduction into 
the abdomen and primary repair was done.  Both in the right and left 
sided Congenital Diaphragmatic hernia, ICD tube was inserted.  Post 
operative X-ray taken for all patients and checked for adequate repair, 
and for the presence of pneumothorax. ICD tube was removed after 
checking the x-ray on 3rd or 4th postoperative day. Average hospital stay 
was 8 – 10 days.  Only one patient required post operative ventilation and 
that patient recovered well.  
Overall survival rate was 58% which was comparable with other 
major centers. Of the 38 patients in whom we operated 36 patients 
survived (95%) and postoperative mortality rate was 5%. Which is 
considered good when compared to other results.          
We consider that most important factor affecting the overall 
mortality figures in our study has been the admission of an increasing 
proportion of babies who formerly would have died shortly after birth but 
are now diagnosed early, resuscitated, intubated and referred, but who 
finally proved to have insufficient lung tissue for survival.  
 
 
 
 
 
 
CONCLUSION 
In our institution when newborn were admitted with a prenatal 
diagnosis of Congenital Diaphragmatic Hernia (CDH)or when CDH 
babies became symptomatic after birth a careful protocol of respiratory 
assistance was followed. Immediate postnatal intubation was done; mask 
ventilation was avoided; whenever ventilators were available small-
volume, high frequency and reduced peak pressure mechanical 
ventilation was started and continued till stabilization of the baby for 
surgical repair. Pre-ductal and post-ductal percutaneous oxygen saturation 
measurements helped in the assessment of fitness of the child for surgical 
intervention. Inotropic drugs were used as necessary and cardiac function 
and heart anomalies were carefully evaluated. The goal of the 
preoperative treatments was “stabilization” of the child - PaO2 > 40 
mmHg and PaCO2 < 60 mmHg, good myocardial function and adequate 
renal clearance with reduced or withdrawn inotropic drugs. 
Surgical repair of CDH was undertaken only after cardio-
respiratory functions were stabilized. A policy of “delayed” surgery 
coupled with gentle ventilation and was followed. 
 
Congenital Diaphragmatic Hernia (CDH) still continues to show a 
signiﬁcant mortality in our institution. This condition continues to remain 
a signiﬁcant challenge for obstetricians, pediatric surgeons, 
neonatologists, and pediatricintensivists. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig -2.X –ray of Right Side CDH 
 
Fig-3. X –ray of Right Side CDH with Contrast 
 
Fig -4. X –ray of Left Side CDH 
 
 
Fig-5. X –ray of Left Side CDH  
Fig – 6. Right Side CDH with Liver as Content 
 
 
Fig –7.  Content Being Reduced 
 
 
Fig – 8.  Content Being Reduced 
 
 
Fig -9.  Content Reduced and Repair Being Done 
 
 
Fig -10. Left Side CDH Defect Being Shown 
 
 
Fig -11. Left Side CDH Defect Showing Hypoplastic Lung 
 
 
Fig -12. Primary Repair Completed 
 
 
 
Fig -13. Immediate Post operative Period with ICD Tube 
 
 
 
 
 
 Fig-1. Picture Showing Scaphoid Abdomen and increased AP 
Diameter of Chest Wall 
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